NCT00340574View on ClinicalTrials.gov

Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark)

PHASE1CompletedINTERVENTIONAL
0
Timeline

Start Date

March 8, 2005

Study Completion Date

July 2, 2008

Conditions
Healthy VolunteerHV
Interventions
DRUG

AMA1-C1/Alhydrogel + CpG 7909

Trial Locations (2)

14642

University of Rochester, Rochester

20892

National Institute of Allergy and Infectious Diseases (NIAID), 9000 Rockville Pi, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00340574 - Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark) | Biotech Hunter | Biotech Hunter